These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3339605)

  • 1. Nitrosoimidazoles: highly bactericidal analogues of 5-nitroimidazole drugs.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    J Med Chem; 1988 Feb; 31(2):323-9. PubMed ID: 3339605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    Biochem Pharmacol; 1988 Jul; 37(13):2603-6. PubMed ID: 3390219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some nitroimidazole derivatives as possible antibacterial agents.
    Demirayak S; Kiraz N
    Farmaco; 1993 Mar; 48(3):443-6. PubMed ID: 8323675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial activities of some new nitroimidazole derivatives.
    Benkli K; Karaburun AC; Gündoğdu-Karaburun N; Demirayak S; Güven K
    Arch Pharm Res; 2003 Oct; 26(10):773-7. PubMed ID: 14609122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae.
    Tweit RC; Muir RD; Ziecina S
    J Med Chem; 1977 Dec; 20(12):1697-700. PubMed ID: 412966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological properties of 1-methyl-2-[(4-aminophenyl)-sulfonyl-]amino-5-nitro imidazole.
    Bertolini A; Castelli M; Borella F; Dall' Asta L; Comini A; Alberti D; Coppi G
    Boll Chim Farm; 1989 Feb; 128(2):71-3. PubMed ID: 2775520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles.
    Letafat B; Emami S; Aliabadi A; Mohammadhosseini N; Moshafi MH; Asadipour A; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2008 Aug; 341(8):497-501. PubMed ID: 18618489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro studies of two 5-nitroimidazole derivatives.
    Castelli M; Malagoli M; Ruberto AI; Baggio A; Casolari C; Cermelli C; Bossa MR; Rossi T; Paolucci F; Roffia S
    J Antimicrob Chemother; 1997 Jul; 40(1):19-25. PubMed ID: 9249200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
    Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
    J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent.
    Mulcahy RT; Gipp JJ; Ublacker GA; McClelland RA
    Biochem Pharmacol; 1990 Dec; 40(12):2671-6. PubMed ID: 2260990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
    Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.
    Hof H; Ströder J; Buisson JP; Royer R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):679-83. PubMed ID: 3800344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-2-nitroimidazol-5-yl derivatives. IVth Communication.
    Cavalleri B; Volpe G; Arioli V; Lancini GC
    Arzneimittelforschung; 1977 Jul; 27(7):1391-2. PubMed ID: 332192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
    Nagarajan K; Gowrishankar R; Arya VP; George T; Nair MD; Shenoy SJ; Sudarsanam V
    Indian J Exp Biol; 1992 Mar; 30(3):193-200. PubMed ID: 1512026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-Disubstituted 5-Nitroimidazoles Potent against Clostridium difficile.
    Spitz C; Mathias F; Péchiné S; Doan THD; Innocent J; Pellissier S; Di Giorgio C; Crozet MD; Janoir C; Vanelle P
    ChemMedChem; 2019 Mar; 14(5):561-569. PubMed ID: 30644169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol-mediated incorporation of radiolabel from 1-[14C]-methyl-4-phenyl-5-nitrosoimidazole into DNA. A model for the biological activity of 5-nitroimidazoles.
    Ehlhardt WJ; Goldman P
    Biochem Pharmacol; 1989 Apr; 38(7):1175-80. PubMed ID: 2523218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activities of nitrothiazole derivatives.
    Hof H; Zak O; Schweizer E; Denzler A
    J Antimicrob Chemother; 1984 Jul; 14(1):31-9. PubMed ID: 6384174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mutagenicity of nitroimidazoles.
    Voogd CE
    Mutat Res; 1981 May; 86(3):243-77. PubMed ID: 6457989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.